FMO5 and chronic kidney disease: The upregulation of inflammatory markers observed in CKD patients (including platelet-derived growth factor and tumor necrosis factor-α) results in NADPH oxidase activation and subsequent generation of intracellular O2• and H2O2 [48,49].